{"id":"healive-healive","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site pain or soreness"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This is an inactivated combination vaccine containing hepatitis A virus antigen and hepatitis B surface antigen (HBsAg). It works by presenting these antigens to the immune system, triggering the production of specific antibodies and cellular immunity against both viruses, thereby providing protection against infection with hepatitis A and B.","oneSentence":"Healive+Healive is a hepatitis A and hepatitis B combination vaccine that stimulates the immune system to produce antibodies against both hepatitis A and B viruses.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:31:52.655Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of hepatitis A infection"},{"name":"Prevention of hepatitis B infection"}]},"trialDetails":[{"nctId":"NCT06058416","phase":"PHASE4","title":"Immunogenicity and Safety of Hepatitis A Among People Aged 18-50 Years Old","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2023-10-24","conditions":"Hepatitis A","enrollment":1092},{"nctId":"NCT02445703","phase":"PHASE4","title":"Comparison of Immunization Schedules of Inactivated Hepatitis A Vaccine and Combined Hepatitis A and Hepatitis B Vaccine","status":"COMPLETED","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2014-05","conditions":"Hepatitis A, Hepatitis B","enrollment":301},{"nctId":"NCT00534885","phase":"PHASE4","title":"Safety, Immunogenicity, and Immune Persistence Study of an Inactivated Hepatitis A Vaccine","status":"COMPLETED","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2006-03","conditions":"Hepatitis A","enrollment":400},{"nctId":"NCT01865968","phase":"PHASE4","title":"Comparison of Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines in Young Adults","status":"COMPLETED","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2008-10","conditions":"Hepatitis A","enrollment":239},{"nctId":"NCT01252680","phase":"PHASE4","title":"Immunogenicity and Interchangeability of Two Inactivated Hepatitis A Vaccines","status":"COMPLETED","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2010-04","conditions":"Hepatitis A","enrollment":303}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Hepatitis A vaccine"],"phase":"marketed","status":"active","brandName":"Healive+Healive","genericName":"Healive+Healive","companyName":"Sinovac Biotech Co., Ltd","companyId":"sinovac-biotech-co-ltd","modality":"Biologic","firstApprovalDate":"","aiSummary":"Healive+Healive is a hepatitis A and hepatitis B combination vaccine that stimulates the immune system to produce antibodies against both hepatitis A and B viruses. Used for Prevention of hepatitis A infection, Prevention of hepatitis B infection.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}